Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

TRANSGENIC MOUSE PRODUCES CF REGULATOR

Jan. 21, 1992

DEPRENYL USA RAISES $15 MILLION IN IPO

Jan. 21, 1992

GENENTECH SEEKS BUYER FOR PARTNERSHIP

Jan. 21, 1992

CYTOGEN BEGINS THROMBOSCAN TRIALS

Jan. 21, 1992

IRELAND APPROVES ROBERTS CANCER TREATMENT

Jan. 21, 1992

FDA PANEL ENDORSES CHIRON'S PROLEUKIN

Jan. 20, 1992

AMYLIN IPO RAISES $56 MILLION

Jan. 20, 1992

AMGEN SEEKS G-CSF PATENT PROTECTION

Jan. 20, 1992

ECOGEN PRIVATE PLACEMENT RAISES $8M

Jan. 20, 1992

IDEXX SETS PRICE FOR ACQUISITION

Jan. 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...